Halagon 0.5mg/ml
Oral solution for calves
Composition
Halofuginone (as lactate salt): 0.50 mg eq. to 0.6086 mg of halofuginone lactate.
Pharmacotherapeutic category
Antiprotozoal agents.
Pharmacotherapeutic category
The active substance, halofuginone, is an antiprotozoal agent of the quinazolinone derivatives group (nitrogenous polyheterocycles). Halofuginone lactate is a salt whose antiprotozoal properties and efficacy against Cryptosporidium parvum have been demonstrated both in in vitro conditions and in artificial and natural infections. The compound has a cryptosporidiostatic effect on Cryptosporidium parvum. It is mainly active on the free stages of the parasite (sporozoïte, merozoïte). The concentrations to inhibit 50% and 90% of the parasites, in an in vitro test system, are IC50 < 0.1 μg/ml and IC90 of 4.5 μg/ml, respectively.
Indications
In newborn calves:
- Prevention of diarrhoea due to diagnosed Cryptosporidium parvum infection, in farms with history of cryptosporidiosis.
- Reduction of diarrhoea due to diagnosed Cryptosporidium parvum infection.
Dosage, route and method of administration
Administration after feeding: 100 μg of halofuginone / kg bw / once a day for 7 consecutive days, i.e. 4 ml of HALAGON / 20 kg bw / once a day for 7 consecutive days.
Shelf-life
2 years.
Packaging
Cardboard box containing one bottle (high-density polyethylene) of 290 ml, 490 ml or 980 ml.
Guidance document for correct use of the dosing device: download pdf.
Guidance video for correct use of the dosing device:
The trade name and/or the specifications of the product (target animal species, indications, dosage and administration, precautions and warnings, etc.) may differ from country to country. Please contact us for further information.